2 results match your criteria: "Division of Dermatology and Virginia Clinical Research Inc[Affiliation]"
Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.
J Eur Acad Dermatol Venereol
November 2015
Division of Evidence Based Medicine (dEBM), Department of Dematology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Background: Actinic keratosis (AK) is a frequent health condition attributable to chronic exposure to ultraviolet radiation. Several treatment options are available and evidence based guidelines are missing.
Objectives: The goal of these evidence- and consensus-based guidelines was the development of treatment recommendations appropriate for different subgroups of patients presenting with AK.
Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
J Am Acad Dermatol
October 2008
Eastern Virginia Medical School, Division of Dermatology and Virginia Clinical Research Inc, Norfolk, Virginia 23507, USA.
Background: The use of light-emitting diode light offers practical advantages in photodynamic therapy (PDT) with topical methyl-aminolevulinate (MAL) for management of actinic keratoses (AK).
Objective: We sought to evaluate the efficacy of MAL PDT using red light-emitting diode light.
Methods: We conducted a multicenter, double-blind, randomized study.